Status:

COMPLETED

Contactless Detection of Sleep Apnea

Lead Sponsor:

Sleepiz AG

Conditions:

Sleep Apnea

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

In this study the inestigators aim to validate the performance of Sleepiz One+ for sleep apnea detection during routine diagnostic sleep studies. Patients who are prescribed polysomnography study will...

Eligibility Criteria

Inclusion

  • Age \>18years
  • Ability and consent to undergo electrophysiological routine assessment
  • Patients suspected to suffer from sleep apnea or any other sleep related disorder

Exclusion

  • Previous enrollment into the current study,
  • Enrollment of the investigator, his/her family members and other dependent persons
  • Cardiac pacemaker or another implanted electrical device
  • Women who are pregnant or breastfeeding
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, delirium etc. of the participant

Key Trial Info

Start Date :

December 7 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 21 2021

Estimated Enrollment :

116 Patients enrolled

Trial Details

Trial ID

NCT04670848

Start Date

December 7 2020

End Date

December 21 2021

Last Update

January 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Universitätsmedizin Essen Ruhrlandklinik

Essen, North Rhine-Westphalia, Germany, 45239